Literature DB >> 21350573

Comment on 'Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial'.

T Fayers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21350573      PMCID: PMC3178136          DOI: 10.1038/eye.2011.18

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  1 in total

1.  Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial.

Authors:  M L Subramanian; G Abedi; S Ness; E Ahmed; M Fenberg; M K Daly; A Houranieh; E B Feinberg
Journal:  Eye (Lond)       Date:  2010-10-01       Impact factor: 3.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.